Using a more sensitive ELISA kit in the current experiment, we confirmed significant increases in CCL17 and CCL22 BAL fluid levels in IPF patients as compared with those in CVD-IP patients and healthy volunteers. The gene discussed is CCL22; the disease is incontinentia pigmenti.